ClinicalTrials.Veeva

Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Macular Edema
Obesity

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Dietary Supplement: Colecalciferol 2000 IU

Phase 3

Diamyd Medical

Barcelona, Spain and 58 other locations

This is a multi-center, prospective, open label study of the Duodenal Glycemic Control™ procedure on type 2 diabetes patients sub-optimally ...

Enrolling
Diabetes Mellitus, Type 2
Device: DiaGone™
Digma Medical

Barcelona, Spain and 4 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 180 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

This Phase 2 study is conducted to investigate the safety and efficacy of runcaciguat in the treatment of diabetic retinopathy. To assess ef...

Active, not recruiting
Diabetic Retinopathy
Drug: Runcaciguat (BAY1101042)
Other: Placebo

Phase 2

Bayer
Bayer

Barcelona, Spain and 49 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Enrolling
Diabetes Mellitus, Type 1
Biological: TCD601
Other: Placebo

Phase 2

ITBMed

Barcelona, Spain and 37 other locations

Study to assess the effects of weekly subcutaneous administration of the GLP1-RA semaglutide 2.4mg on kidney function parameters in obese/overweight...

Invitation-only
Albuminuria
Obesity
Drug: Placebo
Drug: Semaglutide

Phase 3

University Medical Center Groningen (UMCG)

Barcelona, Spain and 12 other locations

The study is a Phase 2, multicounty, multicenter, non-confirmatory, investigator- and subject masked, randomized, placebo-controlled study to evaluat...

Active, not recruiting
Type 1 Diabetes Mellitus
Drug: CFZ533
Other: Placebo

Phase 2

Novartis
Novartis

Barcelona, Cataluna, Spain and 12 other locations

We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doi...

Active, not recruiting
Diabetes Mellitus, Type 2
Chronic Kidney Disease
Drug: Semaglutide
Drug: Placebo (Semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 32 other locations

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 466 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems